Biological Functions of Decorin in Cancer

Overview

Journal Chin J Cancer

Publisher Biomed Central

Specialty Oncology

Date 2013 Apr 23

PMID 23601240

Citations 20

Authors

Xiu-Li Bi

Wancai Yang

Affiliations

Soon will be listed here.

Abstract

Decorin is a member of the extracellular matrix small leucine-rich proteoglycans family that exists and functions in stromal and epithelial cells. Accumulating evidence suggests that decorin affects the biology of various types of cancer by directly or indirectly targeting the signaling molecules involved in cell growth, survival, metastasis, and angiogenesis. More recent studies show that decorin plays important roles during tumor development and progression and is a potential cancer therapeutic agent. In this article, we summarize recent studies of decorin in cancer and discuss decorin's therapeutic and prognostic value.

Citing Articles

Effects of short- and long-term exercise training on cancer cells in vitro: Insights into the mechanistic associations.

Bettariga F, Taaffe D, Galvao D, Newton R J Sport Health Sci. 2024; 14:100994.

PMID: 39370102 PMC: 11863286. DOI: 10.1016/j.jshs.2024.100994.

Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling.

Aljagthmi W, Alasmari M, Daghestani M, Al-Kharashi L, Al-Mohanna F, Aboussekhra A Cells. 2024; 13(8.

PMID: 38667295 PMC: 11049637. DOI: 10.3390/cells13080680.

RBM15 Knockdown Impairs the Malignancy of Cervical Cancer by Mediating m6A Modification of Decorin.

Wang H, Li C, Wei Q, Zhang E, Yang Y, Sha L Biochem Genet. 2024; 63(1):225-238.

PMID: 38429603 DOI: 10.1007/s10528-024-10757-x.

Immunostaining for VEGF and Decorin Predicts Poor Survival and Recurrence in Canine Soft Tissue Sarcoma.

Bray J, Perrott M, Munday J Vet Sci. 2023; 10(4).

PMID: 37104411 PMC: 10143017. DOI: 10.3390/vetsci10040256.

Regulation of Molecular Targets in Osteosarcoma Treatment.

Celik B, Cicek K, Leal A, Tomatsu S Int J Mol Sci. 2022; 23(20).

PMID: 36293439 PMC: 9604206. DOI: 10.3390/ijms232012583.

References

CSORDAS G, Santra M, Reed C, Eichstetter I, McQuillan D, Gross D . Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem. 2000; 275(42):32879-87. DOI: 10.1074/jbc.M005609200. View

Schaefer L, Iozzo R . Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem. 2008; 283(31):21305-9. PMC: 2490788. DOI: 10.1074/jbc.R800020200. View

Iozzo R, Chakrani F, Perrotti D, McQuillan D, Skorski T, Calabretta B . Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc Natl Acad Sci U S A. 1999; 96(6):3092-7. PMC: 15900. DOI: 10.1073/pnas.96.6.3092. View

Goldoni S, Seidler D, Heath J, Fassan M, Baffa R, Thakur M . An antimetastatic role for decorin in breast cancer. Am J Pathol. 2008; 173(3):844-55. PMC: 2527080. DOI: 10.2353/ajpath.2008.080275. View

Smetsers T, van de Westerlo E, Ten Dam G, Overes I, Schalkwijk J, van Muijen G . Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis. J Invest Dermatol. 2004; 122(3):707-16. DOI: 10.1111/j.0022-202X.2004.22316.x. View

Gialeli C, Kletsas D, Mavroudis D, Kalofonos H, Tzanakakis G, Karamanos N . Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies. Curr Med Chem. 2009; 16(29):3797-804. DOI: 10.2174/092986709789177984. View

Tralhao J, Schaefer L, Micegova M, Evaristo C, Schonherr E, Kayal S . In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer. FASEB J. 2003; 17(3):464-6. PMC: 5913819. DOI: 10.1096/fj.02-0534fje. View

Baghy K, Iozzo R, Kovalszky I . Decorin-TGFβ axis in hepatic fibrosis and cirrhosis. J Histochem Cytochem. 2012; 60(4):262-8. PMC: 3351239. DOI: 10.1369/0022155412438104. View

Neill T, Painter H, Buraschi S, Owens R, Lisanti M, Schaefer L . Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem. 2011; 287(8):5492-506. PMC: 3285326. DOI: 10.1074/jbc.M111.283499. View

10.

Theocharis A . Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim Biophys Acta. 2002; 1588(2):165-72. DOI: 10.1016/s0925-4439(02)00161-8. View

11.

Bi X, Pohl N, Qian Z, Yang G, Gou Y, Guzman G . Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice. Carcinogenesis. 2011; 33(2):326-30. PMC: 3271272. DOI: 10.1093/carcin/bgr293. View

12.

Mefford D, Mefford J . Stromal genes add prognostic information to proliferation and histoclinical markers: a basis for the next generation of breast cancer gene signatures. PLoS One. 2012; 7(6):e37646. PMC: 3377707. DOI: 10.1371/journal.pone.0037646. View

13.

Zhu J, Goldoni S, Bix G, Owens R, McQuillan D, Reed C . Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem. 2005; 280(37):32468-79. DOI: 10.1074/jbc.M503833200. View

14.

Nash M, Loercher A, Freedman R . In vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin. Cancer Res. 2000; 59(24):6192-6. View

15.

Bi X, Tong C, Dockendorff A, Bancroft L, Gallagher L, Guzman G . Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. Carcinogenesis. 2008; 29(7):1435-40. PMC: 2811538. DOI: 10.1093/carcin/bgn141. View

16.

Iozzo R, Schaefer L . Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J. 2010; 277(19):3864-75. PMC: 3000440. DOI: 10.1111/j.1742-4658.2010.07797.x. View

17.

Matsumine A, Shintani K, Kusuzaki K, Matsubara T, Satonaka H, Wakabayashi T . Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors. J Surg Oncol. 2007; 96(5):411-8. DOI: 10.1002/jso.20745. View

18.

Santra M, Eichstetter I, Iozzo R . An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem. 2000; 275(45):35153-61. DOI: 10.1074/jbc.M006821200. View

19.

Buraschi S, Pal N, Tyler-Rubinstein N, Owens R, Neill T, Iozzo R . Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels. J Biol Chem. 2010; 285(53):42075-85. PMC: 3009933. DOI: 10.1074/jbc.M110.172841. View

20.

Biglari A, Bataille D, Naumann U, Weller M, Zirger J, Castro M . Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model. Cancer Gene Ther. 2004; 11(11):721-32. PMC: 2902255. DOI: 10.1038/sj.cgt.7700783. View